The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Liver Disease due to Alpha-1 Antitrypsin Deficiency: Are we surprised that it is more complex than we thought?
Di Bisceglie AM1, Teckman J2. Hepatology. 2019 May 6. doi: 10.1002/hep.30694. [Epub ahead of print]
Author information
1 Departments of Internal Medicine.
2 Pediatrics, Saint Louis University School of Medicine.
Abstract
Alpha-1 antitrypsin deficiency (AATD) resulting from mutations in the SERPINA1 gene is associated with decreased circulating level of alpha-1 antitrypsin, and homozygosity for the Z allele is well-known to result in both lung disease (in the form of emphysema) and liver disease (1). Historically, the liver disease has been described as being different at different times in life. Thus, AATD is a cause of neonatal hepatitis and jaundice (2), has been shown to be associated with a picture of chronic hepatitis and, finally, is associated with cirrhosis and end stage liver disease including hepatocellular carcinoma (HCC) (2-4). This article is protected by copyright. All rights reserved.